Pierian
Genomics in Practice
Genomics in Practice
Pierian is a biotechnology and healthcare company founded in 2014, headquartered in the United States. The company's mission, summarized by their slogan "Genomics in Practice," revolves around partnering in precision medicine to advance clinical genomics programs and modernize patient care. With a strong belief in the potential of genomics to transform human health, Pierian positions itself as a facilitator, ensuring that communities worldwide can access the benefits of genomic insights. Through advanced interpretation technology connected to a comprehensive genomic knowledgebase, Pierian empowers healthcare providers with the tools they need to deliver on the promise of precision care. Their most recent investment, a debt financing round, occurred on 02 November 2021. The investors in this latest round are currently undisclosed.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | Unknown | - | 02 Nov 2021 | |
| Series B | $27.00M | 6 |
|
28 Oct 2019 |
| Series A | $9.25M | 4 |
|
07 Jan 2016 |
| Series A | $3.90M | 3 |
|
16 Jun 2015 |
No recent news or press coverage available for Pierian.
We care about your data, and we'd love to use cookies make your experience better.
